Kimura T[au] - Search Results

Year	Number of Results
1918	1
1946	2
1947	1
1948	2
1949	1
1950	1
1951	3
1952	1
1953	1
1954	2
1955	2
1956	1
1957	4
1958	1
1959	2
1960	2
1961	3
1962	11
1963	9
1964	11
1965	14
1966	24
1967	22
1968	22
1969	28
1970	25
1971	29
1972	24
1973	30
1974	26
1975	37
1976	34
1977	40
1978	50
1979	44
1980	47
1981	49
1982	63
1983	58
1984	53
1985	73
1986	64
1987	57
1988	71
1989	106
1990	104
1991	105
1992	96
1993	118
1994	127
1995	124
1996	138
1997	151
1998	165
1999	151
2000	175
2001	178
2002	175
2003	176
2004	210
2005	214
2006	204
2007	242
2008	237
2009	279
2010	304
2011	330
2012	386
2013	368
2014	377
2015	385
2016	425
2017	474
2018	475
2019	458
2020	548
2021	624
2022	286

1

CAR T cells produced in vivo to treat cardiac injury.

Rurik JG, Tombácz I, Yadegari A, Méndez Fernández PO, Shewale SV, Li L, Kimura T, Soliman OY, Papp TE, Tam YK, Mui BL, Albelda SM, Puré E, June CH, Aghajanian H, Weissman D, Parhiz H, Epstein JA. Rurik JG, et al. Among authors: kimura t. Science. 2022 Jan 7;375(6576):91-96. doi: 10.1126/science.abm0594. Epub 2022 Jan 6. Science. 2022. PMID: 34990237

2

New Guideline Diagnosis of Fibrotic Hypersensitivity Pneumonitis in Idiopathic Pulmonary Fibrosis.

Takei R, Yamano Y, Kataoka K, Yokoyama T, Matsuda T, Kimura T, Ozasa M, Fukuoka J, Johkoh T, Kondoh Y. Takei R, et al. Among authors: kimura t. Am J Respir Crit Care Med. 2021 Sep 1;204(5):603-605. doi: 10.1164/rccm.202102-0407LE. Am J Respir Crit Care Med. 2021. PMID: 34033521 No abstract available.

3

An RNA aptamer restores defective bone growth in FGFR3-related skeletal dysplasia in mice.

Kimura T, Bosakova M, Nonaka Y, Hruba E, Yasuda K, Futakawa S, Kubota T, Fafilek B, Gregor T, Abraham SP, Gomolkova R, Belaskova S, Pesl M, Csukasi F, Duran I, Fujiwara M, Kavkova M, Zikmund T, Kaiser J, Buchtova M, Krakow D, Nakamura Y, Ozono K, Krejci P. Kimura T, et al. Sci Transl Med. 2021 May 5;13(592):eaba4226. doi: 10.1126/scitranslmed.aba4226. Sci Transl Med. 2021. PMID: 33952673

4

P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials.

Valgimigli M, Gragnano F, Branca M, Franzone A, Baber U, Jang Y, Kimura T, Hahn JY, Zhao Q, Windecker S, Gibson CM, Kim BK, Watanabe H, Song YB, Zhu Y, Vranckx P, Mehta S, Hong SJ, Ando K, Gwon HC, Serruys PW, Dangas GD, McFadden EP, Angiolillo DJ, Heg D, Jüni P, Mehran R. Valgimigli M, et al. Among authors: kimura t. BMJ. 2021 Jun 16;373:n1332. doi: 10.1136/bmj.n1332. BMJ. 2021. PMID: 34135011 Free PMC article.

5

Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer.

Wu K, Feng J, Lyu F, Xing F, Sharma S, Liu Y, Wu SY, Zhao D, Tyagi A, Deshpande RP, Pei X, Ruiz MG, Takahashi H, Tsuzuki S, Kimura T, Mo YY, Shiozawa Y, Singh R, Watabe K. Wu K, et al. Among authors: kimura t. Nat Commun. 2021 Aug 31;12(1):5196. doi: 10.1038/s41467-021-25473-y. Nat Commun. 2021. PMID: 34465793 Free PMC article.

6

Systemic therapies for metastatic hormone-sensitive prostate cancer: network meta-analysis.

Mori K, Mostafaei H, Sari Motlagh R, Pradere B, Quhal F, Laukhtina E, Schuettfort VM, Kramer G, Abufaraj M, Karakiewicz PI, Kimura T, Egawa S, Shariat SF. Mori K, et al. Among authors: kimura t. BJU Int. 2022 Apr;129(4):423-433. doi: 10.1111/bju.15507. Epub 2021 Jul 21. BJU Int. 2022. PMID: 34171173 Review.

7

Bleeding avoidance strategies in percutaneous coronary intervention.

Capodanno D, Bhatt DL, Gibson CM, James S, Kimura T, Mehran R, Rao SV, Steg PG, Urban P, Valgimigli M, Windecker S, Angiolillo DJ. Capodanno D, et al. Among authors: kimura t. Nat Rev Cardiol. 2022 Feb;19(2):117-132. doi: 10.1038/s41569-021-00598-1. Epub 2021 Aug 23. Nat Rev Cardiol. 2022. PMID: 34426673 Review.

8

Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA).

Hamanishi J, Takeshima N, Katsumata N, Ushijima K, Kimura T, Takeuchi S, Matsumoto K, Ito K, Mandai M, Nakai H, Sakuragi N, Watari H, Takahashi N, Kato H, Hasegawa K, Yonemori K, Mizuno M, Takehara K, Niikura H, Sawasaki T, Nakao S, Saito T, Enomoto T, Nagase S, Suzuki N, Matsumoto T, Kondo E, Sonoda K, Aihara S, Aoki Y, Okamoto A, Takano H, Kobayashi H, Kato H, Terai Y, Takazawa A, Takahashi Y, Namba Y, Aoki D, Fujiwara K, Sugiyama T, Konishi I. Hamanishi J, et al. Among authors: kimura t. J Clin Oncol. 2021 Nov 20;39(33):3671-3681. doi: 10.1200/JCO.21.00334. Epub 2021 Sep 2. J Clin Oncol. 2021. PMID: 34473544 Clinical Trial.

9

Diagnosis and Treatment of Prostate Adenocarcinoma.

Kimura S, Kimura T. Kimura S, et al. Among authors: kimura t. Cancers (Basel). 2021 Jul 21;13(15):3660. doi: 10.3390/cancers13153660. Cancers (Basel). 2021. PMID: 34359561 Free PMC article.

10

Inhibition of FGFR Reactivates IFNγ Signaling in Tumor Cells to Enhance the Combined Antitumor Activity of Lenvatinib with Anti-PD-1 Antibodies.

Adachi Y, Kamiyama H, Ichikawa K, Fukushima S, Ozawa Y, Yamaguchi S, Goda S, Kimura T, Kodama K, Matsuki M, Miyano SW, Yokoi A, Kato Y, Funahashi Y. Adachi Y, et al. Among authors: kimura t. Cancer Res. 2022 Jan 15;82(2):292-306. doi: 10.1158/0008-5472.CAN-20-2426. Epub 2021 Nov 9. Cancer Res. 2022. PMID: 34753772

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results